Gadolinium Carbide is
available in numerous forms and custom shapes including Ingot, foil, rod, plate and sputtering target. High purity forms also include Carbide powder, submicron powder and nanoscale, single crystal or polycrystalline forms. Gadolinium Carbide is generally immediately available in most volumes.American Elements produces to many standard grades when applicable, including Mil Spec (military grade); ACS, Reagent and Technical Grade; Food, Agricultural and Pharmaceutical Grade; Optical Grade, USP and EP/BP (European Pharmacopoeia/British Pharmacopoeia)and follows applicable ASTM testing standards.Typical and custom packaging is available. Additional technical, research and safety (MSDS) information is available as is a Reference Calculator for converting relevant units of measurement.
Like diamond, a pure carbon compound, Carbide compounds tend to be extremely hard, refractory and resistant to wear, corrosion and heat, making them excellent candidates for coatings for drills and other tools. They often have other valuable properties in combination with toughness, such as electrical conductivity, low thermal expansion and abrasiveness.
Gadolinium is a Block F, Group 3, Period 6 element. The number of electrons in each of Gadolinium's shells is 2, 8, 18, 25, 9, 2 and its electronic configuration is [Xe] 4f7 5d1 6s2. In its elemental form gadolinium's CAS number is 7440-54-2. The gadolinium atom has a radius of 178.7.pm and it's Van der Waals radius is unknown. Gadolinium is very toxic. Gadolinium is utilized for both its high magnetic moment (7.94µB) and in phosphors and scintillator material. When complexed with EDTA ligands, it is used as an injectable contrast agent for patients undergoing magnetic resonance imaging. With its high magnetic moment, gadolinium can reduce relaxation times and thereby enhance signal intensity. The extra stable half-full 4f electron shell with no low lying energy levels creates applications as an inert phosphor host. Gadolinium can therefore act as hosts for x-ray cassettes and in scintillator materials for computer tomography. Gadolinium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. Gadolinium was first discovered by Jean de Marignac in 1880. The element is named after the Finnish chemist and geologist Johan Gadolin. See Gadolinium research below.
Feasibility of Using MR Enterography (MRE) for the Assessment of Terminal Ileitis and Inflammatory Activity in Children with Crohn's Disease (CD).
Silverstein J, Grand D, Kawatu D, Shah SA, Steinkeler J, Leleiko N.
J Pediatr Gastroenterol Nutr. 2012 Jan 10. [Epub ahead of print]
PMID:
22241511
[PubMed - as supplied by publisher]
[Pleomorphic adenoma of parotid gland: MR imaging findings].
Zhang B, Shi HM.
Shanghai Kou Qiang Yi Xue. 2011 Dec;20(6):648-52. Chinese.
PMID:
22241320
[PubMed - in process]
CMR With Late Gadolinium Enhancement in Genotype Positive-Phenotype Negative Hypertrophic Cardiomyopathy.
Rowin EJ, Maron MS, Lesser JR, Maron BJ.
JACC Cardiovasc Imaging. 2012 Jan;5(1):119-22. No abstract available.
PMID:
22239901
[PubMed - in process]
Peptide-mediated nanoengineering of inorganic particle sur-faces: A general route toward surface functionalization via peptide adhesion domains.
Schwemmer T, Baumgartner J, Faivre D, Boerner HG.
J Am Chem Soc. 2011 Dec 23. [Epub ahead of print]
PMID:
22239472
[PubMed - as supplied by publisher]
Aqueductal developmental venous anomaly as an unusual cause of congenital hydrocephalus: a case report and review of the literature.
Paulson D, Hwang SW, Whitehead WE, Curry DJ, Luerssen TG, Jea A.
J Med Case Reports. 2012 Jan 11;6(1):7. [Epub ahead of print]
PMID:
22236945
[PubMed - as supplied by publisher]
MR Imaging and CT Evaluation of Congenital Pulmonary Vein Abnormalities in Neonates and Infants.
Vyas HV, Greenberg SB, Krishnamurthy R.
Radiographics. 2012 Jan;32(1):87-98.
PMID:
22236895
[PubMed - in process]
In vivo MRI Characterization of Progressive Cardiac Dysfunction in the mdx Mouse Model of Muscular Dystrophy.
Stuckey DJ, Carr CA, Camelliti P, Tyler DJ, Davies KE, Clarke K.
PLoS One. 2012;7(1):e28569. Epub 2012 Jan 3.
PMID:
22235247
[PubMed - in process]
Impact of inflammation on brain volume in multiple sclerosis.
Cheriyan J, Kim S, Wolansky LJ, Cook SD, Cadavid D.
Arch Neurol. 2012 Jan;69(1):82-8.
PMID:
22232347
[PubMed - in process]
A calcium-permeable non-selective cation channel in the thick ascending limb apical membrane of the mouse kidney.
Guinamard R, Paulais M, Lourdel S, Teulon J.
Biochim Biophys Acta. 2011 Dec 31. [Epub ahead of print]
PMID:
22230350
[PubMed - as supplied by publisher]
Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
Murakami T, Imai Y, Okada M, Hyodo T, Lee WJ, Kim MJ, Kim T, Choi BI.
Oncology. 2011;81 Suppl 1:86-99. Epub 2011 Dec 22.
PMID:
22212941
[PubMed - in process]
Diagnostic imaging of hepatocellular carcinoma: recent progress.
Kudo M.
Oncology. 2011;81 Suppl 1:73-85. Epub 2011 Dec 22.
PMID:
22212940
[PubMed - in process]
Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic Acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alaboudy A, Inoue T, Hatanaka K, Chung H, Hyodo T, Kumano S, Murakami T, Moustafa EF, Kudo M.
Oncology. 2011;81 Suppl 1:66-72. Epub 2011 Dec 22.
PMID:
22212939
[PubMed - in process]
Gd(2)O(3) nanoparticles in hematopoietic cells for MRI contrast enhancement.
Hedlund A, Ahrén M, Gustafsson H, Abrikossova N, Warntjes M, Jönsson JI, Uvdal K, Engström M.
Int J Nanomedicine. 2011;6:3233-40. Epub 2011 Dec 9.
PMID:
22228991
[PubMed - in process]
Hepatic Uptake of Tc-99m DPD on Bone Scintigraphy: The Influence of the Interval With Gadolinium-Containing Contrast of MRI.
Pak K, Kim SJ, Kim IJ, Suh KT.
Clin Nucl Med. 2012 Feb;37(2):134-6.
PMID:
22228334
[PubMed - in process]
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.
Kanki A, Tamada T, Higaki A, Noda Y, Tanimoto D, Sato T, Higashi H, Ito K.
Magn Reson Imaging. 2012 Jan 5. [Epub ahead of print]
PMID:
22227353
[PubMed - as supplied by publisher]
A simple way to acquire T(1)-weighted MR images of rat liver with respiratory triggering.
Morikawa S, Murayama H, Fujimoto S, Shiino A, Inubushi T.
Magn Reson Imaging. 2012 Jan 5. [Epub ahead of print]
PMID:
22227350
[PubMed - as supplied by publisher]
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial.
Miller DH, Weber T, Grove R, Wardell C, Horrigan J, Graff O, Atkinson G, Dua P, Yousry T, Macmanus D, Montalban X.
Lancet Neurol. 2012 Jan 5. [Epub ahead of print]
PMID:
22226929
[PubMed - as supplied by publisher]
Potential of the gastric motility drug lorglumide in prostate cancer imaging.
Sturzu A, Sheikh S, Klose U, Echner H, Kalbacher H, Deeg M, Nägele T, Horger M, Schwentner C, Ernemann U, Heckl S.
Eur J Pharm Sci. 2011 Dec 30. [Epub ahead of print]
PMID:
22226647
[PubMed - as supplied by publisher]
Assessment of Distribution and Evolution of Mechanical Dyssynchrony in a Porcine Model of Myocardial Infarction by Cardiovascular Magnetic Resonance.
Abd-Elmoniem KZ, Santaularia Tomas M, Sasano T, Soleimanifard S, Vonken EJ, Youssef A, Agarwal H, Dimaano VL, Calkins H, Stuber M, Prince JL, Abraham TP, Abraham MR.
J Cardiovasc Magn Reson. 2012 Jan 6;14(1):1. [Epub ahead of print]
PMID:
22226320
[PubMed - as supplied by publisher]
Hyperpolarized 13C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization.
Bohndiek SE, Kettunen MI, Hu DE, Brindle KM.
Cancer Res. 2012 Jan 5. [Epub ahead of print]
PMID:
22223844
[PubMed - as supplied by publisher]